Background & Aims There is controversy over whether use of non-vitamin K antagonist oral
anticoagulants (NOACs) associates with increased risk of major gastrointestinal bleeding …

Non-variceal gastrointestinal bleeding (GIB) is a significant cause of mortality and morbidity
worldwide which is encountered in the ambulatory and hospital settings. Hemorrhage form …

Background & Aims Scoring systems are suboptimal for determining risk in patients with
upper gastrointestinal bleeding (UGIB); these might be improved by a machine learning …

Background and Purpose ATB‐346 is a hydrogen sulfide (H2S)‐releasing anti‐inflammatory
and analgesic drug. Animal studies demonstrated negligible gastrointestinal (GI) damage …

Background & Aims We performed a large, multicenter, randomized controlled trial to
determine the efficacy and safety of early colonoscopy on outcomes of patients with acute …

Importance Lower gastrointestinal bleeding (LGIB), which manifests as blood in the colon or
anorectum, is a common reason for hospitalization. In most patients, LGIB stops …

Importance Epidemiological data on lower gastrointestinal bleeding (GIB) in the general
population are sparse. Objective To describe the incidence, recurrence, mortality, and case …

With the increasing use of nonsteroidal anti-inflammatory drugs (NSAIDs), the incidence of
lower gastrointestinal (GI) complications is expected to increase. However, unlike upper GI …

The approach to the patient with gastrointestinal bleeding (GIB) can be very complex. A
multidisciplinary panel of physicians with expertise in Gastroenterology, Anesthesiology …

Nonsteroidal anti-inflammatory drug (NSAID)-induced enteropathy is considered a serious
and increasing clinical problem without available treatment. Glycomacropeptide (GMP) is a …